000 01489 a2200421 4500
005 20250516032939.0
264 0 _c20110916
008 201109s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-11-134
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTimke, Carmen
245 0 0 _aRandomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer.
_h[electronic resource]
260 _bBMC cancer
_cApr 2011
300 _a134 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aHumans
650 0 4 _aImmunomodulation
_xradiation effects
650 0 4 _aNeoplasm Staging
650 0 4 _aPancreatic Neoplasms
_ximmunology
650 0 4 _aRadiotherapy Dosage
700 1 _aWinnenthal, Hubertus Schmitz
700 1 _aKlug, Felix
700 1 _aRoeder, Falk F F
700 1 _aBonertz, Andreas
700 1 _aReissfelder, Christoph
700 1 _aRochet, Nathalie
700 1 _aKoch, Moritz
700 1 _aTjaden, Christine
700 1 _aBuechler, Markus W
700 1 _aDebus, Juergen
700 1 _aWerner, Jens
700 1 _aBeckhove, Philipp
700 1 _aWeitz, Jürgen
700 1 _aHuber, Peter E
773 0 _tBMC cancer
_gvol. 11
_gp. 134
856 4 0 _uhttps://doi.org/10.1186/1471-2407-11-134
_zAvailable from publisher's website
999 _c20755791
_d20755791